stockrowThe Chemours Company
CC Basic Materials Specialty Chemicals
The Chemours Company’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, roughly unchanged from fiscal 2024.
- Revenue
- +3.01%
- EPS
- +223.8%
- Free cash flow
- −12.5%
- Total debt
- −7.64%
Quarter to September 2026, against a year earlier
Follow CC
Alert me
The Chemours Company (CC) Current ratio
The Chemours Company's current ratio at the end of the quarter to 30 September 2026 was 1.8×, up 0.0× from fiscal 2025 (1.8×). Over the past ten years it has ranged from 1.4× (fiscal 2016) to 2.1× (fiscal 2017); the current reading is higher than 55% of that period. That is below the Specialty Chemicals industry median of 2.3× and below the Basic Materials sector median of 2.5×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 1.8× | 7.38% |
| FY2024 | 1.7× | 7.46% |
| FY2023 | 1.5× | (9.24%) |
| FY2022 | 1.7× | (5.59%) |
| FY2021 | 1.8× | (1.40%) |
| FY2020 | 1.8× | 1.32% |
| FY2019 | 1.8× | (6.48%) |
| FY2018 | 1.9× | (9.09%) |
| FY2017 | 2.1× | 47.02% |
| FY2016 | 1.4× | (8.15%) |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 1.8× | 8.96% |
| Jun 2026 | 1.7× | (8.64%) |
| Mar 2026 | 1.8× | 2.24% |
| Dec 2025 | 1.8× | 4.34% |
| 42 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| STDN Standard Nuclear Inc compare | 12.9× |
| IOSP Innospec Inc. compare | 2.9× |
| WDFC WD-40 Company compare | 2.6× |
| KWR Quaker Houghton compare | 2.5× |
| FUL H. B. Fuller Company compare | 1.8× |
| CC The Chemours Company | 1.8× |
| NGVT Ingevity Corporation compare | 1.6× |
| MTX Minerals Technologies Inc. compare | 1.5× |
| SCL Stepan Company compare | 1.3× |
| Specialty Chemicals industry median | 2.3× |
| Basic Materials sector median | 2.5× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on CC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement